Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;9(3):435-448.
doi: 10.12997/jla.2020.9.3.435. Epub 2020 Sep 21.

The Potential Role of Dyslipidemia in COVID-19 Severity: an Umbrella Review of Systematic Reviews

Geun Joo Choi  1   2 , Hyun Min Kim  2   3 , Hyun Kang  1   2
Affiliations

The Potential Role of Dyslipidemia in COVID-19 Severity: an Umbrella Review of Systematic Reviews

Geun Joo Choi et al. J Lipid Atheroscler. 2020 Sep.

Abstract

Objective: The aim of this study was to analyze the available knowledge about the potential association between dyslipidemia and the severity of coronavirus disease 2019 (COVID-19) as reported in previous published systematic reviews.

Methods: In this umbrella review (an overview of systematic reviews), we investigated the association between dyslipidemia and COVID-19 severity. A systematic search was performed of 4 main electronic databases (MEDLINE, Embase, Scopus, and the Cochrane Library databases) from inception until August 2020. We evaluated the methodological quality of the included studies using the A MeaSurement Tool to Assess systematic Reviews (AMSTAR) 2 tool and used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence for the outcome. In addition, we evaluated the strengths and limitations of the evidence and the methodological quality of the available studies.

Results: Out of 35 articles identified, 2 systematic reviews were included in the umbrella review. A total of 7,951 COVID-19-positive patients were included. According to the AMSTAR 2 criteria and GRADE system, the quality of the included studies was not high. A history of dyslipidemia is likely to be associated with the severity of COVID-19 infection, but the contrary is the case for cholesterol levels at hospitalization.

Conclusions: Although existing research on dyslipidemia and COVID-19 is limited, our findings suggest that dyslipidemia may play a role in the severity of COVID-19 infection. More adequately powered studies are needed.

Trial registration: PROSPERO Identifier: CRD42020205979.

Keywords: COVID-19; Cholesterol; Dyslipidemias; Hyperlipidemias; severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare. Hyun Min Kim and Hyun Kang are editors of Journal of Lipid and Atherosclerosis; however, they were not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1. Flow diagram of studies identified and selected.
Fig. 2
Fig. 2. Forest plot of the severity of COVID-19 disease in patients with or without dyslipidemia: dyslipidemia group versus non-dyslipidemia group.
COVID-19, coronavirus disease 2019; CI, confidence interval; df, degrees of freedom.
Fig. 3
Fig. 3. Forest plot of lipid profiles according to the severity of COVID-19 disease: non-severe group versus severe group.
COVID-19, coronavirus disease 2019; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SD, standard deviation; CI, confidence interval; df, degrees of freedom.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wortham JM, Lee JT, Althomsons S, Latash J, Davidson A, Guerra K, et al. Characteristics of persons who died with COVID-19 - United States, February 12–May 18, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:923–929. - PubMed
    1. Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J. 2020;56:2002108. - PMC - PubMed
    1. Hartmann-Boyce J, Gunnell J, Drake J, Otunla A, Suklan J, Schofield E, et al. Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evid Based Med. 2020 Forthcoming. - PubMed
    1. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15:e0233147. - PMC - PubMed
    1. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–810. - PMC - PubMed